Safety Pharmacology Society 2023 Annual Meeting

  • Start Date/Time :
  • End Date/Time :
  • Location : Brussels, Belgium

A number of HESI Committees will be presenting at the 2023 SPS Annual Meeting.


Botanical Safety Consortium

  • From neat compounds to complex mixtures: A potential screening strategy for cardiotoxic potential of botanicals. P132. Presented by Matthias Gossmann, innoVitro GmbH & Jennifer Pierson, HESI

Cardiac Safety Committee

  • An Evaluation of Drug-Induced Blood Pressure Changes in a Standard Canine CV Safety Pharmacology Study: A HESI-sponsored consortium, Koshman et al., P26. Presented by Yevgeniya Koshman, AbbVie
  • In Vitro Assessment of Long-Term Cardiotoxicity Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Kettenhofen et al. P107. Presented by Ralf Kettenhofen, Fraunhofer IBMT
  • Development of a Pharmaceutical Database to support the Nonclinical Evaluation of Drug-Induced Cardiac Toxicity, De Alwis et al., P138. Presented by Jennifer Pierson, HESI
  • Heart Rate Corrected JTp and TpTe as Proarrhythmia Biomarkers in Safety Pharmacology Non-Human Primate Studies: Outcome from a HESI Consortium Prospective Study, Authier et al., P025. Presented by Todd Wisialowski, Pfizer
  • The Impact of Collaborative Science on Cardiovascular Safety Evaluation – A 10-Year Update of the HESI Cardiac Safety Committee, Blinova et al., P140. Presented by Jennifer Pierson & Claire O'Brien, HESI

View meeting website here.

Contact Us

Health and Environmental Sciences Institute (HESI)
Phone: +1-202-659-8404
Fax: +1-202-659-3859

740 15th Street NW, Suite 600
Washington, DC 20005

Stay Informed

Sign up for our monthly e-newsletter.